{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T05:03:56Z","timestamp":1784178236200,"version":"3.55.0"},"reference-count":24,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T00:00:00Z","timestamp":1784160000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Thymomas are rare epithelial tumors of the anterior mediastinum associated with autoimmune disease, particularly myasthenia gravis (MG). The coexistence of thymoma, MG, and systemic lupus erythematosus (SLE) is uncommon and can complicate diagnosis due to overlapping autoimmune manifestations. Management of advanced thymoma is challenging given limited prospective data and an uncertain optimal role for neoadjuvant therapy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>A 32-year-old woman with systemic lupus erythematosus (SLE) presented with progressive proximal muscle weakness, diplopia, and dysphagia. Examination and serologic testing confirmed MG with elevated acetylcholine receptor antibodies. Chest computed tomography showed an anterior mediastinal mass (8.7 \u00d7 6.0 \u00d7 8.8\u00a0cm) abutting major mediastinal vessels, including the left superior pulmonary vein, main pulmonary artery trunk, left atrial appendage, and left brachiocephalic vein with concern for vascular invasion, along with pleural drop metastases. CT-guided core needle biopsy demonstrated thymoma, and the disease was staged as clinical stage IVA (cT2N0M1a). She received four cycles of cisplatin, doxorubicin, and cyclophosphamide (CAP) followed by two cycles of carboplatin and paclitaxel. Neoadjuvant therapy led to significant clinical improvement, near-complete resolution of dysphagia and weakness, marked radiographic tumor regression, and disappearance of pleural lesions. She subsequently underwent median sternotomy with extended thymectomy and en bloc resection of involved mediastinal tissues. Final pathology confirmed predominantly type B3 thymoma with negative margins. Postoperative radiotherapy was administered. At latest follow-up, she had complete resolution of MG symptoms and no radiographic evidence of recurrent disease.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>\n                      This case highlights challenges in managing\n                      <jats:italic>de novo<\/jats:italic>\n                      stage IVA thymoma with concurrent autoimmune disease and demonstrates that neoadjuvant chemotherapy can enable complete resection of advanced disease. Unlike our prior rheumatologic report on this patient, which focused on the SLE\u2013MG coexistence, this report emphasizes multidisciplinary oncologic management of stage IVA thymoma, including neoadjuvant chemotherapy, surgical resection, adjuvant radiotherapy, and oncologic outcomes. Detailed reporting of such cases remains important to guide treatment strategies for advanced thymoma.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1828735","type":"journal-article","created":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:21:30Z","timestamp":1784175690000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Neoadjuvant chemotherapy enabling resection of stage IVA thymoma with myasthenia gravis and systemic lupus erythematosus: a case report"],"prefix":"10.3389","volume":"16","author":[{"given":"Carlos A.","family":"Cedeno","sequence":"first","affiliation":[{"name":"Hematology and Medical Oncology Section, Department of Medicine, University of Puerto Rico School of Medicine","place":["San Juan, Puerto Rico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgardo","family":"Santiago","sequence":"additional","affiliation":[{"name":"Hematology and Medical Oncology Section, Department of Medicine, University of Puerto Rico School of Medicine","place":["San Juan, Puerto Rico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R.","family":"Cede\u00f1o","sequence":"additional","affiliation":[{"name":"Centro Cardiovascular de Puerto Rico y del Caribe, University of Puerto Rico School of Medicine","place":["San Juan, Puerto Rico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Lafontaine","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Puerto Rico School of Medicine","place":["San Juan, Puerto Rico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria J.","family":"Marcos","sequence":"additional","affiliation":[{"name":"Department of Pathology and Laboratory Medicine, University of Puerto Rico School of Medicine","place":["San Juan, Puerto Rico"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Concepci\u00f3n","sequence":"additional","affiliation":[{"name":"Department of Radiology, University of Puerto Rico School of Medicine","place":["San Juan, Puerto Rico"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,7,16]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0b013e3181f1f62d","article-title":"Epidemiology of thymoma and associated Malignancies","volume":"5","author":"Engels","year":"2010","journal-title":"J Thorac Oncol"},{"key":"B2","doi-asserted-by":"publisher","first-page":"200394","DOI":"10.1183\/16000617.0394-2020","article-title":"Thymic epithelial tumours: from basic principles to individualised treatment strategies","volume":"30","author":"Girard","year":"2021","journal-title":"Eur Respir Rev"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1007\/s10067-020-05061-z","article-title":"A tale of autoimmunity: thymoma, thymectomy, and systemic lupus erythematosus","volume":"39","author":"Mollaeian","year":"2020","journal-title":"Clin Rheumatol"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.20452\/pamw.773","article-title":"Systemic lupus erythematosus and myasthenia gravis","volume":"119","author":"Hrycek","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1007\/s00415-011-6335-z","article-title":"The association of systemic lupus erythematosus and myasthenia gravis: a series of 17 cases, with a special focus on hydroxychloroquine use and a review of the literature","volume":"259","author":"Jallouli","year":"2012","journal-title":"J Neurol"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.4236\/ojra.2014.43021","article-title":"Rare case of a patient with newly diagnosed thymoma presenting with paraneoplastic systemic lupus erythematosus, myasthenia gravis, and hypogammaglobulinemia","volume":"4","author":"Hansra","year":"2014","journal-title":"Open J Rheumatol Autoimmune Dis"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.4103\/ijn.IJN_12_18","article-title":"Systemic lupus erythematosus and myasthenia gravis: a rare association","volume":"29","author":"Nagarajan","year":"2019","journal-title":"Indian J Nephrol"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/S0003-4975(03)00555-1","article-title":"Therapy for thymic epithelial tumors: a clinical study of 1,320 patients from Japan","volume":"76","author":"Kondo","year":"2003","journal-title":"Ann Thorac Surg"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2020.05.088","article-title":"Management and long-term outcomes of advanced stage thymoma in the United States","volume":"111","author":"Khorfan","year":"2021","journal-title":"Ann Thorac Surg"},{"key":"B10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/jso.25981","article-title":"Importance of resection for locoregional disease control in Masaoka stage IVA thymic neoplasms","volume":"122","author":"Corsini","year":"2020","journal-title":"J Surg Oncol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1155\/crrh\/7670778","article-title":"Thymoma-associated systemic lupus erythematosus and myasthenia gravis","volume":"2026","author":"Gonz\u00e1lez-Ramos","year":"2026","journal-title":"Case Rep Rheumatol"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.athoracsur.2004.12.047","article-title":"Advanced stage thymomas and thymic carcinomas: results of multimodality treatments","volume":"79","author":"Lucchi","year":"2005","journal-title":"Ann Thorac Surg"},{"key":"B13","article-title":"Thymomas and thymic carcinomas (Version 1.2026)","volume-title":"NCCN Clinical Practice Guidelines in Oncology","year":"2025"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1994.12.6.1164","article-title":"Cisplatin plus doxorubicin plus cyclophosphamide in metastatic or recurrent thymoma: final results of an intergroup trial. Eastern Cooperative Oncology Group, Southwest Oncology Group, and Southeastern Cancer Study Group","volume":"12","author":"Loehrer","year":"1994","journal-title":"J Clin Oncol"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1002\/cam4.4711","article-title":"Clinical outcomes for patients with thymoma and thymic carcinoma after undergoing different front-line chemotherapy regimens","volume":"11","author":"Ma","year":"2022","journal-title":"Cancer Med"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.32.9607","article-title":"Phase II study of carboplatin and paclitaxel in advanced thymoma and thymic carcinoma","volume":"29","author":"Lemma","year":"2011","journal-title":"J Clin Oncol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000030867","article-title":"Prognostic factors for overall survival after surgical resection in patients with thymic epithelial tumors: a systematic review and meta-analysis","volume":"101","author":"Li","year":"2022","journal-title":"Med (Baltimore)"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1097\/JTO.0000000000000290","article-title":"The IASLC\/ITMIG Thymic Epithelial Tumors Staging Project: proposal for an evidence-based stage classification system for the forthcoming (8th) edition of the TNM classification of malignant tumors","volume":"9","author":"Detterbeck","year":"2014","journal-title":"J Thorac Oncol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1440-1827.1994.tb02936.x","article-title":"A review of 79 thymomas: modification of staging system and reappraisal of conventional division into invasive and non-invasive thymoma","volume":"44","author":"Koga","year":"1994","journal-title":"Pathol Int"},{"key":"B20","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1016\/j.jtcvs.2019.11.114","article-title":"A national analysis of open versus minimally invasive thymectomy for stage I to III thymoma","volume":"160","author":"Yang","year":"2020","journal-title":"J Thorac Cardiovasc Surg"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1111\/his.14167","article-title":"Interobserver variation in the classification of thymic lesions including biopsies and resection specimens in an international digital microscopy panel","volume":"77","author":"Wolf","year":"2020","journal-title":"Histopathology"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2021.10.010","article-title":"The 2021 WHO classification of tumors of the thymus and mediastinum: what is new in thymic epithelial, germ cell, and mesenchymal tumors","volume":"17","author":"Marx","year":"2022","journal-title":"J Thorac Oncol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.21875","article-title":"Preoperative steroid pulse therapy for invasive thymoma: clinical experience and mechanism of action","volume":"106","author":"Kobayashi","year":"2006","journal-title":"Cancer"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1016\/j.nrl.2019.12.001","article-title":"Systemic lupus erythematosus in thymectomized patients with myasthenia gravis: reports of three clinical cases","volume":"36","author":"Alba Isasi","year":"2021","journal-title":"Neurologia (Engl Ed)"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1828735\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,16]],"date-time":"2026-07-16T04:21:31Z","timestamp":1784175691000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1828735\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,16]]},"references-count":24,"alternative-id":["10.3389\/fonc.2026.1828735"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1828735","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,16]]},"article-number":"1828735"}}